FRIDAY, Nov. 18, 2022 (HealthDay News) — Patients with systemic lupus erythematosus who are treated with lower doses of hydroxychloroquine have an increased risk for hospitalizations for flares, according to a study presented at the annual meeting of the American College of Rheumatology, held from Nov. 10 to 14 in Philadelphia.
Foot/Ankle Injury During Football Career Linked to Foot/Ankle OA 
Sex-Based Differences Affect S2-Alar-Iliac Screw Placement in Spinal Deformity Surgery 
Methotrexate Cuts Systolic BP in Rheumatoid Arthritis 
Features of Immunesenescence Present in Early Stages of Rheumatoid Arthritis 
Lentiviral Gene Therapy Shows Sustained Clinical Efficacy for ADA-SCID 
Cocoa Extract Supplementation Yields Significant Reduction in hsCRP 
Population Aging Contributes to Burden of Musculoskeletal Disorders 
Digital Intervention Aids Psychological Outcomes With Inflammatory Rheumatic Diseases 
